Skip to main content



) --

ICU Medical



) hit a new 52-week high Wednesday as it is currently trading at $53.99, above its previous 52-week high of $53.98 with 13,722 shares traded as of 11:59 a.m. ET. Average volume has been 90,000 shares over the past 30 days.

ICU Medical has a market cap of $754.8 million and is part of the

health care

sector and

health services

industry. Shares are up 19.5% year to date as of the close of trading on Tuesday.

TheStreet Recommends

ICU Medical, Inc. engages in the development, manufacture, and sale of medical technologies used in infusion therapy, oncology, and critical care applications. The company has a P/E ratio of 17.2, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

TheStreet Ratings rates ICU Medical as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full

ICU Medical Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center